Thomas K Equels Aim Immuno Tech Inc. (AIM) insider trading activity

Thomas K Equels is CEO & President of AIM ImmunoTech Inc.. Currently has a direct ownership of 1.55 Million shares of AIM, which is worth approximately $357,182. The most recent transaction as insider was on Nov 20, 2024, when has been sold 60,110 shares (Common Stock) at a price of $0.18 per share, resulting in proceeds of $10,819. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.55M

34.39% 3M change

155.91% 12M change

Total Value Held $357,182

Thomas K Equels Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2024	BUY Open market or private purchase	$10,819 $0.18 p/Share	60,110 Added 3.73%	1,552,968 Common Stock
Sep 16 2024	BUY Open market or private purchase	$1,500 $0.3 p/Share	5,000 Added 0.33%	1,493,042 Common Stock
Sep 13 2024	BUY Open market or private purchase	$6,200 $0.31 p/Share	20,000 Added 1.33%	1,488,042 Common Stock
Sep 11 2024	BUY Grant, award, or other acquisition	$100,000 $0.32 p/Share	312,500 Added 17.55%	1,468,042 Common Stock
Aug 12 2024	BUY Grant, award, or other acquisition	$98,113 $0.26 p/Share	377,358 Added 24.62%	1,155,542 Common Stock
May 06 2024	BUY Open market or private purchase	$24,691 $0.4 p/Share	61,729 Added 7.35%	778,184 Common Stock
Mar 15 2024	BUY Open market or private purchase	$25,000 $0.33 p/Share	75,758 Added 9.56%	716,455 Common Stock
Nov 27 2023	BUY Open market or private purchase	$14,898 $0.44 p/Share	33,861 Added 5.02%	640,697 Common Stock
Sep 29 2023	BUY Open market or private purchase	$9,977 $0.44 p/Share	22,676 Added 3.6%	606,836 Common Stock
Aug 25 2023	BUY Open market or private purchase	$5,508 $0.67 p/Share	8,222 Added 1.39%	584,160 Common Stock
Aug 24 2023	BUY Open market or private purchase	$10,045 $0.67 p/Share	14,993 Added 2.54%	575,938 Common Stock
Jul 17 2023	BUY Open market or private purchase	$10,000 $0.59 p/Share	16,950 Added 2.93%	560,945 Common Stock
Jan 03 2023	BUY Open market or private purchase	$50,000 $0.31 p/Share	161,291 Added 22.87%	543,995 Common Stock
Jul 18 2022	BUY Grant, award, or other acquisition	$25,000 $0.76 p/Share	32,895 Added 7.92%	382,704 Common Stock
Apr 25 2022	BUY Grant, award, or other acquisition	$50,000 $1.02 p/Share	49,020 Added 12.29%	349,809 Common Stock
Dec 13 2021	BUY Grant, award, or other acquisition	$25,000 $1.16 p/Share	21,552 Added 6.69%	300,789 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	$15,000 $1.27 p/Share	11,811 Added 4.06%	279,237 Common Stock
Nov 24 2021	BUY Grant, award, or other acquisition	$14,999 $1.29 p/Share	11,627 Added 4.17%	267,426 Common Stock
Nov 23 2021	BUY Grant, award, or other acquisition	$15,000 $1.34 p/Share	11,194 Added 4.19%	255,799 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	$15,000 $1.47 p/Share	10,204 Added 4.0%	244,605 Common Stock
Nov 17 2021	BUY Grant, award, or other acquisition	$14,999 $1.64 p/Share	9,146 Added 3.76%	234,401 Common Stock
Jul 16 2021	BUY Open market or private purchase	$30,000 $1.92 p/Share	15,625 Added 6.49%	225,255 Common Stock
Feb 24 2021	BUY Open market or private purchase	$25,000 $2.26 p/Share	11,062 Added 5.01%	209,630 Common Stock
Dec 17 2020	BUY Open market or private purchase	$25,000 $1.72 p/Share	14,535 Added 6.82%	198,568 Common Stock

TKE

Thomas K Equels

CEO & President

Ocala, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIM shares.

Notify only if

Value

Insider Trading

Get notified when an Aim Immuno Tech Inc. insider buys or sells AIM shares.

Notify only if

Operation

Value

Type

News

Receive news related to AIM ImmunoTech Inc.

Track Activities on AIM

Account